HealthWise KnowledgeBase
Congenital Heart Defects: Prostaglandins and Prostaglandin Inhibitors
Topic Overview
Normally, a blood vessel needed only for
Reference fetal blood circulation Opens New Window Reference
Opens New Window (called the ductus arteriosus) closes off at birth.
During fetal development, this blood vessel is kept open by a naturally
occurring substance in the fetus's body called prostaglandin. At birth, fetal
production of prostaglandin decreases and the ductus arteriosus closes.
In some premature infants, this blood vessel does not close. This is a condition called a Reference patent (open) ductus arteriosus Opens New Window. These premature infants are given a prostaglandin inhibitor, a medicine to stimulate the closure of this blood vessel.
When an infant has certain other Reference congenital heart defects Opens New Window, a medicine (a form of Reference prostaglandin Opens New Window) is often given by vein to keep the ductus arteriosus open. Keeping this blood vessel open allows the blood to continue circulating until surgery or another procedure can be done to correct the related defect and allow normal blood flow.
| By: | Reference Healthwise Staff | Last Revised: Reference October 11, 2011 |
| Medical Review: | Reference John Pope, MD - Pediatrics
Reference Larry A. Latson, MD - Pediatric Cardiology |
|
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.

